Skip to main content
. 2021 Jan 29;56(7):1550–1557. doi: 10.1038/s41409-020-01200-x

Fig. 2. Event free survival and overall survival - Allo-SCT in complete remission versus residual disease.

Fig. 2

A Event-free survival and B overall survival after allogeneic stem cell transplantation (allo-SCT) until relapse/death of disease in patients transplanted in complete remission (CR) versus transplantation in residual disease (RD), respectively. Patients alive at last follow-up were censored. With p values < 0.05 in both analyses, EFS and OS is significantly higher in patients treated in CR.